SAGE Therapeutics is a clinical-stage biopharmaceutical company committed to developing and commercializing novel medicines to treat life-threatening, rare CNS disorders. SAGE's lead program, SAGE-547, is in clinical development for super-refractory status epilepticus and is the first of several compounds the company is developing in its portfolio of potential seizure medicines. SAGE's proprietary chemistry platform has generated multiple new compounds that target GABA A and NMDA receptors, which are broadly accepted as impacting many psychiatric and neurological disorders.
SAGE Therapeutics is a clinical-stage biopharmaceutical company committed to developing and commercializing novel medicines to treat life-threatening, rare CNS disorders. SAGE's lead program, SAGE-547, is in clinical development for super-refractory status epilepticus and is the first of several compounds the company is developing in its portfolio of potential seizure medicines. SAGE's proprietary chemistry platform has generated multiple new compounds that target GABA A and NMDA receptors, which are broadly accepted as impacting many psychiatric and neurological disorders.
Recent Articles
- Explore Carnival's New $600M Celebration Key Destination
- LET Mining Introduces Innovative BTC Cloud Mining Contracts
- Apple Inc. Faces Securities Fraud Allegations with AAPL Stock
- Unlocking Daily Income with RICH Miner's USDC Cloud Mining
- Jensen Huang's diplomatic overtures signal AI's future in China
- Concerns Raised Over BellRing Brands, Inc.'s Financial Integrity
- Allegations Spark Concern: Centene Corporation Faces Legal Scrutiny
- ABQuant Leverages Bitcoin Surge to Boost User Earnings Daily
- Exploring AB Quant: How to Maximize Your Crypto Earnings
- Bitcoin Swift Launches Innovative Presale with Advanced Features
- Bitcoin Solaris: The Future of Mining and Investment Awaits
- AIXA Miner's Bold Move as Bitcoin Hits New Heights in Mining
- Airenteed Heating and Cooling Brings Relief to Seniors
- Troller Cat Hits Over $350K in Presale Contributions
- Key Developments in Satellite Internet That Could Change Everything
- Unlocking Passive Income: RICH Miner’s New XRP Mining System
- Insights from the 2025 Belt and Road Journalists Forum
- Revolutionizing Crypto Mining: AIXA Miner Unveils Game-Changer
- Join the Fraud Investigation Regarding Edgewise Therapeutics Inc.
- Join Fortrea Holdings' Class Action Before Deadline Approaches
- Exploring Timeless Business Opportunities from Retiring Owners
- America's Economic Revival Under Trump: Key Highlights Unveiled
- Economic Growth and Key Developments During Trump's Leadership
- RICH Miner's Innovative XRP Mining Plan: Secure Your Investment
- Investors Urged to Join Hims & Hers Health Legal Action
- Elon Musk's Upcoming Strategic Shift: Insights from Experts
- Important Legal Update for Hims & Hers Health, Inc. Investors
- Unlocking the Potential of Bitcoin Cloud Mining Profits
- Exciting Details About the Upcoming Marucci World Series 2025
- RI Mining Launches Free Cloud Mining Contracts for All Investors
- Tim Walz's Reflections on Leadership Amidst Political Tension
- AIXA Miner: Pioneering Sustainable Cloud Mining Solutions
- AIXA Miner Leads Way in Cloud Mining and Blockchain Trends
- Merck & Co. Faces Investigation: What's Next for Investors?
- Woman Faces Sentencing for Fraud Tied to North Korea
- Unicycive Therapeutics: Investors Alerted on New Developments
- Join the Ongoing Investigation of Altimmune, Inc. Now
- Connie Francis' Lasting Impact on Pop Music and Culture
- Phoebe Gates and Sophia Kianni: Revolutionizing Fashion with Phia
- Trump's GENIUS Act: What It Means for the Crypto Landscape
- Staying Ahead of the Curve: Why Trading Compliance Is Now a Strategic Advantage
- Gleim Aviation Unveils Innovative Pilot Training Solutions
- EarnMining's Revolutionary App Paves the Way for Bitcoin Mining
- Gleim Aviation's Innovative Solutions for Modern Pilot Training
- Renovation Ideas for Community-Driven Spaces
- Rising Concerns: PepGen Inc. Faces Securities Fraud Issues
- Dogecoin to Surge to New Heights, Analyst Predicts 2,600% Rise
- 2025 Payroll Solutions: QuickBooks Payroll Rises to the Top
- Investors of 3D Systems Corporation Seek to Join Class Action
- Meta Enlists Seattle AI Pioneer with Over $100 Million Offer